Compounds > lenvatinib

lenvatinib and Skin-Neoplasms

lenvatinib has been researched along with Skin-Neoplasms* in 3 studies

Reviews

2 review(s) available for lenvatinib and Skin-Neoplasms

ArticleYear
[New molecular target therapy for thyroid neoplasms and malignant melanomas].
    Nihon Jibiinkoka Gakkai kaiho, 2015, Volume: 118, Issue:11

    Topics: Antibodies, Monoclonal; Antineoplastic Agents; Clinical Trials as Topic; Humans; Indoles; Ipilimumab; Melanoma; Molecular Targeted Therapy; Niacinamide; Nivolumab; Phenylurea Compounds; Quinolines; Skin Neoplasms; Sorafenib; Sulfonamides; Thyroid Neoplasms; Vemurafenib

2015
[Preclinical biomarker research and patient stratification of molecular target agents: the anti-angiogenic inhibitor Lenvatinib mesylate (E7080)].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2013, Volume: 142, Issue:4

    Topics: Angiogenesis Inhibitors; Animals; Biomarkers, Tumor; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Melanoma; Molecular Targeted Therapy; Mutation; Neoplasms; Phenylurea Compounds; Precision Medicine; Proto-Oncogene Proteins B-raf; PTEN Phosphohydrolase; Quinolines; Receptors, Vascular Endothelial Growth Factor; Skin Neoplasms; Translational Research, Biomedical

2013

Other Studies

1 other study(ies) available for lenvatinib and Skin-Neoplasms

ArticleYear
Cutaneous finger and tongue metastases in renal cell carcinoma.
    BMJ case reports, 2019, Jun-21, Volume: 12, Issue:6

    Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Everolimus; Fingers; Humans; Kidney Neoplasms; Male; Middle Aged; Phenylurea Compounds; Quinolines; Skin Neoplasms; Tongue Neoplasms

2019